會議議程

Executive Summary：
Dr. Chun-Wei Chang graduated from College of Medicine, Taipei Medical uUniversity, and received her neurological residency training in Chang Gung Memorial Hospital (CGMH). He is currently an Attending Physician in the Department of Neurology at Linkou CGMH in Taiwan. Additionally, he serves as an Adjunct Assistant Professor at the National Tsing Hua University School of Medicine. He possesses a unique interdisciplinary research focus that bridges clinical neurology with computer sciences. With a specific focus on inflammatory conditions such as immune-mediated polyneuropathy, he applied computational models to clinical challenges. Currently, he is an active member in Taiwan Neuroimmunology Medical Society.

Lecture Abstract：
This lecture explores the emerging role of multi-modal biomarkers in advancing precision medicine for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). By integrating traditional clinical assessments with novel fluid markers (serum/CSF), advanced electrodiagnostics, imaging techniques (ultrasound/MRI), and machine learning models, the presentation outlines a comprehensive framework for modern CIDP management. Ultimately, these integrated biomarker profiles enhance diagnostic accuracy, enable precise monitoring of disease activity, and help predict patient responses to immunotherapies.

Executive Summary：
蔡乃文醫師，現任高雄長庚紀念醫院神經內科部主治醫師，並兼任長庚大學醫學系副教授。蔡醫師畢業於高雄醫學大學醫學系，並於國立中山大學生物科學系取得博士學位，長期致力於神經肌肉疾病及神經免疫疾病之臨床與研究。
他曾擔任高雄長庚醫院神經肌肉疾病科主任與長庚鳳山醫院神經內科主任，專長領域涵蓋重症肌無力、多發性硬化症、神經退化性疾病及腦中風等。蔡醫師發表多篇關於神經免疫疾病的研究論文，其中包含探討台灣重症肌無力患者流行病學與治療趨勢的全國性研究。
今日他將為我們帶來題為 「Clinical Characteristics of Myasthenia Gravis Patients in Taiwan」 的專題演講，分享最新的臨床觀察與研究成果。

Lecture Abstract：
Abstract: Title: Clinical Characteristics of Myasthenia Gravis Patients in Taiwan Presenter: Nai-Wen Tsai, MD, PhD Event: Annual Meeting of the Taiwan Neurological Society Myasthenia Gravis (MG) is an autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigability. While the global understanding of MG continues to evolve, regional differences in clinical presentation, antibody status, and treatment response have emerged, underlining the importance of population-specific data. This lecture presents a comprehensive analysis of the clinical characteristics of MG patients in Taiwan, based on data collected from medical research of MG across the country. We will examine the demographic distribution of MG in Taiwan, including age at onset, sex ratio, and regional prevalence. Particular attention is given to the bimodal age distribution, highlighting the differences between early-onset and late-onset MG. The lecture also explores the spectrum of initial symptoms—ocular versus generalized onset—and the rates of progression to generalized MG. Furthermore, t, the role of immunosuppressive therapies, including corticosteroids, azathioprine, and emerging biologics, will also be addressed in the context of Taiwan’s healthcare setting. By comparing our findings with international data, this lecture aims to highlight both shared and unique features of MG in Taiwan. These insights are critical for optimizing diagnostic strategies, tailoring treatment plans, and improving long-term outcomes for Taiwanese patients. The presentation will conclude with proposed directions for future research and the establishment of a national MG registry to facilitate better disease surveillance and management.

Executive Summary：
Dr. Yuan-Ting Sun, MD, PhD, is an Associate Professor in the Department of Neurology at National Cheng Kung University Hospital, Taiwan. With extensive expertise in neuroimmunology, neurogenetics, and neuromuscular disorders, she has made significant contributions to both clinical practice and research.
Dr. Sun completed her medical training and doctoral studies at National Cheng Kung University and further honed his research skills as a postdoctoral fellow at the University of Oxford. Currently, she serves as the Chair of the Neuromuscular Section of the Taiwan Neurological Society and holds key roles in Taiwan’s neuroimmunology and clinical neurophysiology communities. Her work has been widely recognized, earning numerous academic awards for excellence in research and presentation.
As a principal investigator, Dr. Sun has led multiple research projects focusing on precision medicine for hereditary neuromuscular diseases and immune-related neurological disorders. Her publication record and active participation in international conferences highlight her dedication to advancing neurology.
Today, Dr. Sun will share her insights on Japanese Encephalitis drawing upon her extensive experience in both research and patient care.

Lecture Abstract：
Japanese encephalitis (JE) remains the leading cause of vaccine-preventable viral encephalitis in Asia and parts of the Western Pacific. Despite effective vaccination programs, JE continues to pose a public health challenge in regions with incomplete vaccine coverage and favorable transmission conditions.

This lecture will review the key aspects of JE from a clinical perspective, including current approaches to diagnosis, such as clinical recognition, neuroimaging features, and laboratory confirmation through serology and molecular testing. Treatment remains largely supportive, and advances in neurological and critical care management will also be discussed. Finally, the role of vaccination in JE prevention will be highlighted, including available vaccines and strategies for disease control in endemic areas. Together, these perspectives provide an overview of the diagnosis, management, and prevention of Japanese encephalitis.